# A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users

> **NCT02192931** · PHASE4 · COMPLETED · sponsor: **Perry Renshaw** · enrollment: 65 (actual)

## Conditions studied

- Depression
- Dual Diagnosis
- Drug Addiction

## Interventions

- **DRUG:** Creatine monohydrate

## Key facts

- **NCT ID:** NCT02192931
- **Lead sponsor:** Perry Renshaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192931, "A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02192931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*